KP

Koonath Panakkattil Sakkeerali

Active Director Director DIN 10631704
DIN 10631704 First appointment May 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Koonath Panakkattil Sakkeerali

Data last updated:

Koonath Panakkattil Sakkeerali is a Director at Mizali Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10631704
Primary Designation Director
Industry Paper
First Appointment 16 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 May 20242024Active

Board colleagues of Koonath Panakkattil Sakkeerali

Directorship timeline

Open interactive timeline →
Mizali Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Koonath Panakkattil Sakkeerali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Koonath Panakkattil Sakkeerali

Koonath Panakkattil Sakkeerali currently holds 1 directorship: Mizali Pharmaceuticals Private Limited (Director, since 16 May 2024).

Koonath Panakkattil Sakkeerali was first appointed on 16 May 2024 as Director at Mizali Pharmaceuticals Private Limited.

The current boards of Koonath Panakkattil Sakkeerali's companies include Mohammed Fazil (Mizali Pharmaceuticals Private Limited), Shaheer Arakkakattil (Mizali Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available